Tyra Biosciences Inc. (TYRA)
NASDAQ: TYRA
· Real-Time Price · USD
12.54
0.40 (3.29%)
At close: Sep 05, 2025, 10:09 AM
3.29% (1D)
| Bid | 9.01 |
| Market Cap | 667.55M |
| Revenue (ttm) | 496K |
| Net Income (ttm) | -105.83M |
| EPS (ttm) | -1.79 |
| PE Ratio (ttm) | -7.01 |
| Forward PE | -5.45 |
| Analyst | Buy |
| Ask | 15.93 |
| Volume | 20,487 |
| Avg. Volume (20D) | 286,529 |
| Open | 12.19 |
| Previous Close | 12.14 |
| Day's Range | 11.98 - 12.91 |
| 52-Week Range | 6.42 - 29.60 |
| Beta | 1.10 |
About TYRA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol TYRA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for TYRA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 weeks ago
+14.26%
Tyra Biosciences shares are trading higher after t...
Unlock content with
Pro Subscription
10 months ago
-23.35%
Tyra Biosciences shares are trading lower. The company announced clinical proof-of-concept data for TYRA-300 in patients with metastatic urothelial cancer from its ongoing SURF301 Phase 1/2 study.
